By Sam Nussey and Anton Bridge TOKYO (Reuters) -SoftBank CEO Masayoshi Son's plan to invest billions in AI in the United States shows one way to handle the new Trump administration: go big and deal with the details later.

EFishery Pte, one of Indonesia’s most prominent startups, may have inflated its revenue and profit over several years, according to an internal investigation triggered by a whistleblower’s claim about the company’s accounting.

U.S. President Donald Trump announced on January 21 that Japan's SoftBank Group, Open AI and Oracle will together

Masayoshi Son, the billionaire founder and CEO of SoftBank, the Japanese media technology conglomerate, is often cast as a dreamer, financial engineer, and speculator. But his career — which has spanned the launch of the personal computer and internet,

SoftBank Group shares jumped after the company and ChatGPT-maker OpenAI announced plans to invest up to half a trillion dollars in artificial-intelligence infrastructure in the U.S. Shares rose 8.8% to 10,060 yen, or equivalent to $64.69, on Wednesday in Tokyo, after climbing as much as 9.2% earlier, to their highest level since July.

Tokyo stocks ended sharply higher Wednesday, driven by gains in semiconductor-related shares following news that SoftBank Group will

The ChatGPT maker will hold a 40% interest in Stargate, and would act as an extension of OpenAI, the report said, citing OpenAI CEO Sam Altman speaking to colleagues. OpenAI and SoftBank did not immediately respond to Reuters' requests for comment.

US President Donald Trump announced that OpenAI, SoftBank Group and Oracle will unveil Stargate and invest $500 billion over the next four years to help the United States stay ahead of China and other rivals in the global AI race.

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

About 875 acres in Abilene, or roughly the size of New York’s Central Park, have been set aside to construct data centers, according to city documents seen by Bloomberg News. Or

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every